Product NDC: | 55390-071 |
Proprietary Name: | Fenoldopam Mesylate |
Non Proprietary Name: | Fenoldopam Mesylate |
Active Ingredient(s): | 10 mg/mL & nbsp; Fenoldopam Mesylate |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55390-071 |
Labeler Name: | Bedford Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076582 |
Marketing Category: | ANDA |
Start Marketing Date: | 20041014 |
Package NDC: | 55390-071-01 |
Package Description: | 1 VIAL in 1 BOX, UNIT-DOSE (55390-071-01) > 1 mL in 1 VIAL |
NDC Code | 55390-071-01 |
Proprietary Name | Fenoldopam Mesylate |
Package Description | 1 VIAL in 1 BOX, UNIT-DOSE (55390-071-01) > 1 mL in 1 VIAL |
Product NDC | 55390-071 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Fenoldopam Mesylate |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20041014 |
Marketing Category Name | ANDA |
Labeler Name | Bedford Laboratories |
Substance Name | FENOLDOPAM MESYLATE |
Strength Number | 10 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Dopamine Agonists [MoA],Dopaminergic Agonist [EPC] |